AVH 6.30% $2.53 avita medical inc.

NICE perspective on Avita - risks?, page-5

  1. 4,208 Posts.
    lightbulb Created with Sketch. 308
    It was to start in August, just had confirmation that Britain's NHS NICE will start a review of ReCell later this month. IIRC, the previous one on 2014 took about 6-8 weeks, I'm told this one will take up to 6 months.
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.